Fulminant hepatitis C virus infection.
Schirmer
M
M
Vogel
W
W
Thaler
J
J
Grünewald
K
K
Umlauft
F
F
Geisen
F
F
Zilian
U
U
Konwalinka
G
G
D015762:2-Chloroadenosine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D000410:Alanine Transaminase / Q000097:blood; D004796:Clinical Enzyme Tests; D003839:Deoxyadenosines / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006526:Hepatitis C / Q000175:diagnosis / Q000635:transmission*; D006801:Humans; D007943:Leukemia, Hairy Cell / Q000188:drug therapy; D008875:Middle Aged; D065227:Transfusion Reaction
D003839:Deoxyadenosines; D015762:2-Chloroadenosine; C036854:2'-chloro-2'-deoxyadenosine; D000410:Alanine Transaminase